Nugene Intl Inc Financials

NUGN

Source SEC Filings (10-K/10-Q) Updated Sep 30, 2025 Currency USD FYE December

This page shows Nugene Intl Inc (NUGN) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 8 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 40/100

Based on FY2024 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

Nugene Intl Inc has an operating margin of -127.5%, meaning the company retains $-128 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is up from -327.3% the prior year.

Growth

Nugene Intl Inc's revenue declined 15.4% year-over-year, from $2.0M to $1.7M. This contraction results in a growth score of 0/100.

Leverage

100

Nugene Intl Inc carries a low D/E ratio of 0.10, meaning only $0.10 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

100

With a current ratio of 5.01, Nugene Intl Inc holds $5.01 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 100/100.

Cash Flow

While Nugene Intl Inc generated -$156K in operating cash flow, capex of $0 consumed most of it, leaving -$156K in free cash flow. This results in a low score of 0/100, reflecting heavy capital investment rather than weak cash generation.

Piotroski F-Score Weak

3/9

Nugene Intl Inc passes 3 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Low Quality

0.26x

For every $1 of reported earnings, Nugene Intl Inc generates $0.26 in operating cash flow (-$156K OCF vs -$596K net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Revenue

$1.7M

YoY-15.4%

5Y CAGR-4.1%

Nugene Intl Inc generated $1.7M in revenue in fiscal year 2024. This represents a decrease of 15.4% from the prior year.

EBITDA

N/A

Free Cash Flow

-$156K

YoY+64.0%

Nugene Intl Inc generated -$156K in free cash flow in fiscal year 2024, representing cash available after capex. This represents an increase of 64.0% from the prior year.

Net Income

-$596K

YoY+90.9%

Nugene Intl Inc reported -$596K in net income in fiscal year 2024. This represents an increase of 90.9% from the prior year.

EPS (Diluted)

N/A

Cash & Debt

$4K

YoY-87.1%

5Y CAGR-29.6%

Nugene Intl Inc held $4K in cash against $0 in long-term debt as of fiscal year 2024.

Dividends Per Share

N/A

Shares Outstanding

830M

YoY+2.2%

Nugene Intl Inc had 830M shares outstanding in fiscal year 2024. This represents an increase of 2.2% from the prior year.

Gross Margin

-73.6%

YoY-26.9pp

5Y CAGR-145.4pp

Nugene Intl Inc's gross margin was -73.6% in fiscal year 2024, indicating the percentage of revenue retained after direct costs. This is down 26.9 percentage points from the prior year.

Operating Margin

-127.5%

YoY+199.8pp

5Y CAGR+120.1pp

Nugene Intl Inc's operating margin was -127.5% in fiscal year 2024, reflecting core business profitability. This is up 199.8 percentage points from the prior year.

Net Margin

-35.3%

YoY+292.0pp

5Y CAGR+215.1pp

Nugene Intl Inc's net profit margin was -35.3% in fiscal year 2024, showing the share of revenue converted to profit. This is up 292.0 percentage points from the prior year.

Return on Equity

N/A

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

Nugene Intl Inc invested $0 in capex in fiscal year 2024, funding long-term assets and infrastructure.

NUGN Income Statement

Metric	FY24	FY23	FY22	FY21	FY16	FY15
Revenue	$1.7M-15.4%	$2.0M0.0%	$2.0M0.0%	$2.0M+292.6%	$509K-75.6%	$2.1M
Cost of Revenue	$2.9M-0.1%	$2.9M+42.0%	$2.1M+95.5%	$1.1M+47.4%	$719K+22.1%	$589K
Gross Profit	-$1.2M-33.2%	-$935K-789.5%	-$105K-113.5%	$781K+473.1%	-$209K-114.0%	$1.5M
R&D Expenses	N/A	N/A	N/A	N/A	$115K-68.0%	$360K
SG&A Expenses	$912K-83.1%	$5.4M+1406.4%	$358K+7.0%	$335K-72.5%	$1.2M-8.5%	$1.3M
Operating Income	-$2.2M+67.1%	-$6.5M-1014.4%	-$587K-173.7%	-$215K+97.6%	-$9.1M-76.0%	-$5.2M
Interest Expense	N/A	N/A	N/A	N/A	$1.5M+2603.2%	$57K
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	-$596K+90.9%	-$6.5M-1243.7%	-$487K-126.7%	-$215K+98.2%	-$11.8M-126.4%	-$5.2M
EPS (Diluted)	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'25	Q2'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23
Revenue	$329K+40.7%	$234K-21.5%	$298K-46.6%	$559K+82.2%	$307K-37.5%	$491K-16.4%	$587K+36.1%	$431K
Cost of Revenue	$772K+30.6%	$591K-27.4%	$814K+29.9%	$627K-13.8%	$728K+9.7%	$663K-19.8%	$827K+59.7%	$518K
Gross Profit	-$442K-24.0%	-$357K+30.8%	-$516K-656.2%	-$68K+83.8%	-$421K-152.4%	-$167K+30.7%	-$241K-176.8%	-$87K
R&D Expenses	N/A	N/A	N/A	N/A	$5.8M	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Income	-$581K-49.6%	-$388K+63.9%	-$1.1M-948.6%	-$103K+82.0%	-$569K-40.3%	-$406K+65.6%	-$1.2M+52.1%	-$2.5M
Interest Expense	$0	$0-100.0%	$6K-19.6%	$8K+14.8%	$7K	N/A	$0	$0
Income Tax	$0	$0	$0	$0	$0	N/A	$175-85.9%	$1K
Net Income	-$225K-252.8%	$147K+114.7%	-$1.0M-482.4%	$263K-52.7%	$556K+237.0%	-$406K+65.6%	-$1.2M+52.1%	-$2.5M
EPS (Diluted)	N/A	$0.00	N/A	$0.00	N/A	N/A	$0.00	$0.00

NUGN Balance Sheet

Metric	FY24	FY23	FY22	FY21	FY16	FY15
Total Assets	$47.6M+1.6%	$46.9M+101.0%	$23.3M+14.0%	$20.4M+6186.2%	$325K-62.9%	$878K
Current Assets	$3.4M+220.5%	$1.1M+68.0%	$636K+31.3%	$484K+232.4%	$146K-77.5%	$648K
Cash & Equivalents	$4K-87.1%	$31K+26.8%	$24K-95.0%	$484K+987.9%	$45K+94.3%	$23K
Inventory	$0	$0	$0	$0-100.0%	$51K-71.2%	$177K
Accounts Receivable	$3.0M+340.3%	$682K+39.2%	$490K	$0-100.0%	$12K-96.6%	$347K
Goodwill	$0	$0	$0	$0	N/A	N/A
Total Liabilities	$4.2M+8.9%	$3.8M+18.2%	$3.2M+1154.6%	$259K-95.7%	$6.1M+380.9%	$1.3M
Current Liabilities	$683K+66.8%	$410K+102.7%	$202K-21.9%	$259K	N/A	$1.3M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$43.4M+0.9%	$43.0M+114.4%	$20.1M-0.6%	$20.2M+451.8%	-$5.7M-1397.0%	-$383K
Retained Earnings	-$19.7M-3.6%	-$19.0M-52.8%	-$12.5M-4.1%	-$12.0M+34.9%	-$18.4M-179.9%	-$6.6M

Metric	Q3'25	Q2'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23
Total Assets	$44.5M-1.4%	$45.2M-5.1%	$47.6M-1.0%	$48.1M+0.7%	$47.7M+1.8%	$46.9M+0.3%	$46.7M+0.1%	$46.7M
Current Assets	$1.8M-8.2%	$2.0M-41.4%	$3.4M+6.1%	$3.2M+38.0%	$2.3M+118.9%	$1.1M+20.5%	$886K+66.9%	$531K
Cash & Equivalents	$11K-83.8%	$65K+1548.3%	$4K-50.3%	$8K-47.1%	$15K-50.9%	$31K-83.8%	$190K+336.6%	$43K
Inventory	$0	$0	$0	$0	$0	$0	$0	$0
Accounts Receivable	$1.5M-14.7%	$1.7M-43.3%	$3.0M+8.1%	$2.8M+45.9%	$1.9M+179.0%	$682K+85.8%	$367K+77.5%	$207K
Goodwill	$0	$0	$0	$0	$0	$0	$0	$0
Total Liabilities	$2.8M-18.0%	$3.4M-18.4%	$4.2M+1.9%	$4.1M+2.3%	$4.0M+4.5%	$3.8M-5.3%	$4.1M+10.1%	$3.7M
Current Liabilities	$212K-37.8%	$340K-50.2%	$683K+12.8%	$605K+18.0%	$513K+25.2%	$410K-42.5%	$712K+82.2%	$391K
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$41.7M-1.5%	$42.3M-2.5%	$43.4M-0.7%	$43.7M0.0%	$43.7M+1.6%	$43.0M+0.8%	$42.7M-0.6%	$43.0M
Retained Earnings	-$21.1M-3.7%	-$20.4M-3.5%	-$19.7M-7.9%	-$18.3M+1.3%	-$18.5M+2.8%	-$19.0M-2.1%	-$18.6M-7.0%	-$17.4M

NUGN Cash Flow Statement

Metric	FY24	FY23	FY22	FY21	FY16	FY15
Operating Cash Flow	-$156K+64.0%	-$433K-183.0%	$522K-36.3%	$819K+140.9%	-$2.0M+17.7%	-$2.4M
Capital Expenditures	$0	$0	$0	$0-100.0%	$5K-97.6%	$187K
Free Cash Flow	-$156K+64.0%	-$433K-183.0%	$522K-36.3%	$819K+140.8%	-$2.0M+23.4%	-$2.6M
Investing Cash Flow	-$351K+75.2%	-$1.4M+4.4%	-$1.5M-57.8%	-$937K	N/A	N/A
Financing Cash Flow	$480K-74.1%	$1.9M+273.4%	$496K-17.3%	$600K	N/A	$1.3M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'25	Q2'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23
Operating Cash Flow	$53K-89.7%	$508K+265.4%	-$307K-666.9%	-$40K+56.0%	-$91K+61.5%	-$236K-8.3%	-$218K-178.7%	$277K
Capital Expenditures	$0	$0	$0	$0	$0	$0	$0	$0
Free Cash Flow	$53K-89.7%	$508K+265.4%	-$307K-666.9%	-$40K+56.0%	-$91K+61.5%	-$236K-8.3%	-$218K-178.7%	$277K
Investing Cash Flow	-$114K+75.7%	-$468K-484.0%	$122K+2357.7%	$5K+109.3%	-$53K+66.4%	-$159K+33.9%	-$240K+68.4%	-$760K
Financing Cash Flow	$7K+6631.0%	$100-99.9%	$187K+566.5%	$28K-78.2%	$129K-45.4%	$236K-61.0%	$604K+40.8%	$429K
Dividends Paid	N/A	N/A	$0	$0	N/A	N/A	$0	$0
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

NUGN Financial Ratios

Metric	FY24	FY23	FY22	FY21	FY16	FY15
Gross Margin	-73.6%-26.9pp	-46.7%-41.5pp	-5.3%-44.3pp	39.1%+80.2pp	-41.1%-112.9pp	71.8%
Operating Margin	-127.5%+199.8pp	-327.3%-298.0pp	-29.4%-18.6pp	-10.7%+1773.0pp	-1783.7%-1536.1pp	-247.6%
Net Margin	-35.3%+292.0pp	-327.3%-302.9pp	-24.4%-13.6pp	-10.7%+2308.7pp	-2319.4%-2069.1pp	-250.3%
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	-1.3%+12.7pp	-14.0%-11.9pp	-2.1%-1.0pp	-1.1%+3631.8pp	-3632.9%-3038.2pp	-594.7%
Current Ratio	5.01+2.4	2.61-0.5	3.15+1.3	1.87	N/A	0.51
Debt-to-Equity	0.100.0	0.09-0.1	0.16+0.1	0.01+1.1	-1.06+2.2	-3.29
FCF Margin	-9.2%+12.4pp	-21.7%-47.8pp	26.1%-14.8pp	40.9%+435.2pp	-394.2%-268.5pp	-125.8%

Metric	Q3'25	Q2'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23
Gross Margin	-134.3%+18.1pp	-152.4%+20.5pp	-172.9%-160.7pp	-12.2%+125.1pp	-137.3%-103.3pp	-34.0%+7.0pp	-41.0%-20.9pp	-20.2%
Operating Margin	-176.3%-10.4pp	-165.8%+194.5pp	-360.3%-342.0pp	-18.4%+167.3pp	-185.7%-103.0pp	-82.7%+118.6pp	-201.3%+369.9pp	-571.2%
Net Margin	-68.3%-131.3pp	62.9%+399.7pp	-336.8%-383.9pp	47.0%-134.2pp	181.2%+263.9pp	-82.7%+118.6pp	-201.2%+369.9pp	-571.2%
Return on Equity	N/A	0.4%	N/A	0.6%-0.7pp	1.3%	N/A	N/A	N/A
Return on Assets	-0.5%-0.8pp	0.3%+2.4pp	-2.1%-2.7pp	0.5%-0.6pp	1.2%+2.0pp	-0.9%+1.7pp	-2.5%+2.8pp	-5.3%
Current Ratio	8.69+2.8	5.89+0.9	5.01-0.3	5.33+0.8	4.56+2.0	2.61+1.4	1.24-0.1	1.36
Debt-to-Equity	0.07-0.0	0.08-0.0	0.100.0	0.090.0	0.090.0	0.090.0	0.100.0	0.09
FCF Margin	15.9%-201.1pp	217.1%+320.1pp	-103.0%-95.8pp	-7.2%+22.5pp	-29.7%+18.5pp	-48.2%-11.0pp	-37.2%-101.6pp	64.3%

Similar Companies

Generative AI AICOF

$7.3M

Riwi Corp RWCRF

$5.9M

Wishpond Technol WPNDF

$6.5M

Liveworld LVWD

$5.5M

China Yibai CBGH

$7.5M

Frequently Asked Questions

What is Nugene Intl Inc's annual revenue?

Nugene Intl Inc (NUGN) reported $1.7M in total revenue for fiscal year 2024. This represents a -15.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Nugene Intl Inc's revenue growing?

Nugene Intl Inc (NUGN) revenue declined by 15.4% year-over-year, from $2.0M to $1.7M in fiscal year 2024.

Is Nugene Intl Inc profitable?

No, Nugene Intl Inc (NUGN) reported a net income of -$596K in fiscal year 2024, with a net profit margin of -35.3%.

What is Nugene Intl Inc's gross margin?

Nugene Intl Inc (NUGN) had a gross margin of -73.6% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.

What is Nugene Intl Inc's operating margin?

Nugene Intl Inc (NUGN) had an operating margin of -127.5% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.

What is Nugene Intl Inc's net profit margin?

Nugene Intl Inc (NUGN) had a net profit margin of -35.3% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.

What is Nugene Intl Inc's free cash flow?

Nugene Intl Inc (NUGN) generated -$156K in free cash flow during fiscal year 2024. This represents a 64.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Nugene Intl Inc's operating cash flow?

Nugene Intl Inc (NUGN) generated -$156K in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

What are Nugene Intl Inc's total assets?

Nugene Intl Inc (NUGN) had $47.6M in total assets as of fiscal year 2024, including both current and long-term assets.

What are Nugene Intl Inc's capital expenditures?

Nugene Intl Inc (NUGN) invested $0 in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.

How many shares does Nugene Intl Inc have outstanding?

Nugene Intl Inc (NUGN) had 830M shares outstanding as of fiscal year 2024.

What is Nugene Intl Inc's current ratio?

Nugene Intl Inc (NUGN) had a current ratio of 5.01 as of fiscal year 2024, which is generally considered healthy.

What is Nugene Intl Inc's debt-to-equity ratio?

Nugene Intl Inc (NUGN) had a debt-to-equity ratio of 0.10 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Nugene Intl Inc's return on assets (ROA)?

Nugene Intl Inc (NUGN) had a return on assets of -1.3% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

What is Nugene Intl Inc's cash runway?

Based on fiscal year 2024 data, Nugene Intl Inc (NUGN) had $4K in cash against an annual operating cash burn of $156K. This gives an estimated cash runway of approximately 0 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

What is Nugene Intl Inc's Piotroski F-Score?

Nugene Intl Inc (NUGN) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Nugene Intl Inc's earnings high quality?

Nugene Intl Inc (NUGN) has an earnings quality ratio of 0.26x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Nugene Intl Inc?

Nugene Intl Inc (NUGN) scores 40 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.